2019
DOI: 10.1111/jcmm.14361
|View full text |Cite
|
Sign up to set email alerts
|

MicroRNA‐301b‐3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4

Abstract: Micro RNA s (mi RNA s) are key regulators in the tumour growth and metastasis of human hepatocellular carcinoma ( HCC ). Increasing evidence suggests that miR‐301b‐3p functions as a driver in various types of human cancer. However, the expression pattern of miR‐301b‐3p and its functional role as well as underlying molecular mechanism in HCC remain poorly known. Our study found that miR‐301b‐3p expression was significant… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
18
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 29 publications
(20 citation statements)
references
References 35 publications
2
18
0
Order By: Relevance
“…An in vivo tumor growth assay was performed using BALB/C nude mice as previously described 18 . Briefly, 1 × 10 6 Hep3B cell with or without LINC01123 knockdown were injected subcutaneously into nude mice (n=5 per group).…”
Section: Methodsmentioning
confidence: 99%
“…An in vivo tumor growth assay was performed using BALB/C nude mice as previously described 18 . Briefly, 1 × 10 6 Hep3B cell with or without LINC01123 knockdown were injected subcutaneously into nude mice (n=5 per group).…”
Section: Methodsmentioning
confidence: 99%
“…Four-week BALB/c nude mice were purchased from Shanghai SLAC Laboratory Animal Company (Shanghai, China). The in vivo tumor growth and lung metastasis experiments were performed using Hep3B cells with or without USP13 knockdown according to the protocols as previously described (Dou et al, 2019a;Guo et al, 2019). The tumor volume (V) was calculated as follows: V = (L × D2)/2 where L and D represent the tumor length and width, respectively (in mm).…”
Section: In Vivo Experimentsmentioning
confidence: 99%
“…Survival analysis indicated that the survival time of patients with high miR-301b-3p expression was markedly shorter than that of patients with low miR-301b-3p expression; hence, miR-301b-3p was likely to be the disadvantageous prognostic factor of breast cancer ( Figure 1(b) ). Besides, miR-301b-3p is considered to be an oncogene in many researches [ 15 , 16 ]. Accordingly, we detected its expression in breast cancer cells ( Figure 1(c) ) and found that its expression in breast cancer cells MCF7, MDA-MB-231, and SK-BR-3 was noticeably higher than that in normal breast cell Hs 578Bst.…”
Section: Resultsmentioning
confidence: 99%